Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Assessment Test (Marketwire via Yahoo! Finance)
February 9th, 2010 by admin
SEATTLE, WA–(Marketwire – 02/08/10) – Atossa Genetics , Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer , announced today the launch of its new Web site at www.atossagenetics.com . Founded in 2009 by Steven C. Quay, M.D., Ph.D., Atossa Genetics, Inc …
This entry was posted
on Tuesday, February 9th, 2010 at 8:12 am and is filed under Molecular Genetics.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.